SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-19-001165
Filing Date
2019-10-10
Accepted
2019-10-10 21:08:50
Documents
2
Period of Report
2019-10-08

Document Format Files

Seq Description Document Type Size
1 form3-10102019_061034.html 3  
1 form3-10102019_061034.xml 3 1668
2 ex24-10102019_061035.htm EX-24 5276
  Complete submission text file 0001415889-19-001165.txt   8346
Mailing Address 1517 SAN JACINTO HOUSTON TX 77002
Business Address
SAPIRSTEIN JAMES (Reporting) CIK: 0001559509 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 191146939

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations